Jagsonpal Pharmaceuticals Allots 101825 Equity Shares Under JPL ESOP 2022
Jagsonpal Pharmaceuticals Ltd 路 Others (Uncategorized) 路 30 Sept 2026, 9:38 pm
Jagsonpal Pharmaceuticals Allots 101825 Equity Shares Under JPL ESOP 2022 Jagsonpal Pharmaceuticals Limited has allotted 1,01,825 equity shares of face value Rs. 2 each on 30th Sep'26 following the exercise of vested options under the JPL ESOP 2022. The allotment comprises 1,00,000 shares exercised at Rs. 94.00 per share and 1,825 shares at Rs. 115.60 per share. Consequently, the company's paid-up equity capital increased from Rs. 13,19,14,840 (6,59,57,420 shares) to Rs. 13,21,18,490 (6,60,59,245 shares). The newly issued shares rank pari-passu with existing equity shares.
Original exchange filing (PDF)
More announcements from Jagsonpal Pharmaceuticals Ltd
- Earning call transcript for Jagsonpal Pharmaceuticals Limited Q2 FY 27 Earning Conference Call on October 29, 2026 at 2:00 P.M 路 03 Nov 2026
- Audio Recording of Jagsonpal Pharmaceuticals Limited Q2 FY27 Earnings Conference call on October 29, 2026 at 02:00 P.M. 路 29 Oct 2026
- Press Release for Unaudited Financial Results for the quarter September 30, 2026 路 29 Oct 2026
- Press Release for Unaudited Financial Results for the quarter ended September 30, 2026. 路 29 Oct 2026
- Unaudited Financial Results (Standalone & Consolidated for the quarter and half year ended September 30, 2026. 路 28 Oct 2026
- Jagsonpal Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 28 Oct 2026
- Outcome of Board Meeting held on October 28, 2026 along with Unaudited Financial Results(Standalone & Consolidated) for the quarter and half year ended September 30, 2026 路 28 Oct 2026
- JAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 28-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 28 Oct 2026
